[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634388":3},{"organization":4,"outcomesModule":7,"designInfo":40,"detailedDescription":43,"studyPopulation":44,"armGroups":39,"interventions":39,"overallOfficials":39,"centralContacts":45,"locations":51,"responsibleParty":76,"collaborators":39,"id":78,"slug":39,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":39,"eligibilityCriteria":82,"healthyVolunteers":79,"sex":83,"minAge":84,"maxAge":39,"enrollmentInfo":85,"targetDuration":39,"studyType":88,"phases":39,"briefSummary":43,"conditions":89,"keywords":39,"overallStatus":54,"whyStopped":39,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Centro di Riferimento Oncologico - Aviano","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":39},[9],{"measure":10,"description":11,"timeFrame":12},"Change in Quality of Life as measured by the EORTC QLQ-C30 questionnaire.","Mean differences on the questionnaire will be evaluated. The EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire) is a 30-item validated tool used to assess the physical, psychological, and social functions of cancer patients. Higher scores on functional scales and the global health status represent a higher\u002Fbetter level of functioning, while higher scores on symptom scales represent a higher level of symptomatology.","Up to 6 months after the end of the physical activity program",[14,17,20,23,26,30,33,36],{"measure":15,"description":16,"timeFrame":12},"Change from Baseline in Pain Intensity (Brief Pain Inventory - Short Form)","Pain intensity will be assessed using the Brief Pain Inventory (BPI) Severity score, rated on an 11-point Likert scale from 0 (no pain) to 10 (pain as bad as you can imagine). A higher score indicates greater pain intensity.",{"measure":18,"description":19,"timeFrame":12},"Change from Baseline in Physical Activity Levels","Subjective physical fitness and activity will be evaluated using the IPAQ (International Physical Activity Questionnaire). This questionnaire assesses walking, moderate-intensity, and vigorous-intensity activities. Results are reported as Metabolic Equivalent of Task (MET)-minutes per week. Higher MET-minutes indicate higher physical activity levels.",{"measure":21,"description":22,"timeFrame":12},"Change from Baseline in Dietary Habits and Nutritional Intake","Evaluated through food diaries provided during nutritional visits. The diaries assess caloric intake and macronutrient distribution (carbohydrates, proteins, fats).",{"measure":24,"description":25,"timeFrame":12},"Change from Baseline in Blood Test Results","Difference in mean of laboratory parameters as collected during routine nutritional visits to assess the metabolic impact of the program.",{"measure":27,"description":28,"timeFrame":29},"incidence of Hormonal Therapy-Related Toxicities","Frequencies of side effects and toxicities related to hormonal therapy assessed via clinical examination and patient interview according to CTCAE (Common Terminology Criteria for Adverse Events) or standard clinical practice.","Through the end of the program and follow-up (up to 6 months).",{"measure":31,"description":32,"timeFrame":12},"Change from Baseline in BMI","Mean difference in BMI (Body Mass Index)",{"measure":34,"description":35,"timeFrame":12},"Change from Baseline in body measures","Mean difference in body measures such as circumferences and plicometry",{"measure":37,"description":38,"timeFrame":12},"Change from Baseline in BIA","Mean difference in Bioelectrical Impedance Analysis (BIA)",null,{"allocation":39,"interventionModel":39,"interventionModelDescription":39,"primaryPurpose":39,"observationalModel":41,"timePerspective":42,"maskingInfo":39},"COHORT","PROSPECTIVE","The advances in early detection coupled with improvements in treatments have led to an ever-increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may represent valid additions to the currently available treatment options. Interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, improve survival and the quality of life.\n\nThis is an observational, prospective study aimed at evaluating the effects of physical activity on the quality of life of patients with early stage hormone receptor positive breast cancer receiving adjuvant hormonal therapy and adhering to a physical activity program lasting for a total of 12 weeks organized by ANDOS onlus (Associazione Italiana Donne Operate al Seno).","Early stage hormone receptor positive breast cancer patients participating to the Medicina and Sport",[46],{"name":47,"role":48,"phone":49,"phoneExt":39,"email":50},"Mattia Garutti","CONTACT","0434659092","mattia.garutti@cro.it",[52],{"facility":53,"status":54,"city":55,"state":56,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"Centro di Riferimento Oncologico di Aviano","RECRUITING","Aviano","Pordenone","33081","Italy","IT",{"type":61,"coordinates":62},"Point",[63,64],12.59472,46.07056,{"lat":64,"lon":63},[67,69,71,74],{"name":68,"role":48,"phone":49,"phoneExt":39,"email":50},"Mattia Garutti, MD",{"name":68,"role":70,"phone":39,"phoneExt":39,"email":39},"PRINCIPAL_INVESTIGATOR",{"name":72,"role":73,"phone":39,"phoneExt":39,"email":39},"Linda Cucciniello, MD","SUB_INVESTIGATOR",{"name":75,"role":73,"phone":39,"phoneExt":39,"email":39},"Fabio Puglisi, MD, PhD",{"type":77,"investigatorFullName":39,"investigatorTitle":39,"investigatorAffiliation":39,"oldNameTitle":39,"oldOrganization":39},"SPONSOR","100634388",false,"NCT07539038","Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients","Inclusion Criteria:\n\n* Patients with early stage (I-IIIa) hormone receptor-positive breast cancer receiving adjuvant endocrine therapy\n* Female patients ≥18 years of age\n* Written informed consent must be obtained before any study-related assessment is performed\n* Participation to the Medicina and Sport physical activity program organized by Andos Pordenone\n\nExclusion Criteria:\n\n* Patients with early hormone receptor negative breast cancer\n* Patients with early hormone receptor positive breast cancer receiving chemotherapy\n* Patients with advanced\u002Fmetastatic breast cancer.\n* Patients receiving active treatment for secondary primary tumors (excluding basal cell carcinoma or in situ neoplasias).\n* Patients with history of vertebral and\u002For femoral fractures\n* Patients with CVDs not optimally controlled by medical therapy","FEMALE","18 Years",{"count":86,"type":87},44,"ESTIMATED","OBSERVATIONAL",[90],"Breast Cancer","2026-04-13",{"date":93,"type":94},"2026-04-20","ACTUAL",{"date":96,"type":94},"2025-04-03",{"date":98,"type":87},"2027-12-31",{"name":5,"class":6},1]